ホーム › 非小細胞肺癌 › コネチカット州 › Bridgeport
Bridgeport、CTにおける非小細胞肺癌の臨床試験
Bridgeportとその周辺地域（約30マイル以内）の拠点で、非小細胞肺癌に関する14件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
被験者募集中第3相
- Stony Brook University Medical Center, Stony Brook · 18マイル先
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
被験者募集中第3相
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4マイル先
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5マイル先
- Stony Brook University Medical Center, Stony Brook · 18マイル先
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
被験者募集中第1相
- Smilow Cancer Hospital - Trumbull, Trumbull · 4マイル先
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
被験者募集中第3相
- University Hospital at Stony Brook ( Site 0054), Stony Brook · 18マイル先
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
被験者募集中第3相
- Research Site, Stony Brook · 18マイル先
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
被験者募集中第2/3相
- Suny-Stony Brook University Cancer Center, Stony Brook · 18マイル先
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
被験者募集中第1相
- New york cancer and blood specialists - Oncology, Port Jefferson Station · 19マイル先
- New york cancer and blood specialists - Oncology, Port Jefferson Station · 19マイル先
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
被験者募集中第3相
- Stony Brook University Medical Center, Stony Brook · 18マイル先
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
被験者募集中第1相
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Port Jefferson Station · 19マイル先
Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer
被験者募集中第1/2相
- Smilow Cancer Hospital Care Center - Trumbull, Trumbull · 4マイル先
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
被験者募集中第2相
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4マイル先
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5マイル先
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
被験者募集中第2相
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4マイル先
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5マイル先
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
被験者募集中第2/3相
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4マイル先
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5マイル先
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
被験者募集中第2相
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4マイル先
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5マイル先
他の都市における非小細胞肺癌の試験
- Houston, TX145件の研究
- New York City, NY121件の研究
- Arlington, VA104件の研究
- Nashville, TN97件の研究
- Boston, MA90件の研究
- Los Angeles, CA87件の研究
- St. Louis, MO73件の研究
- Chicago, IL61件の研究
- Baltimore, MD60件の研究
- San Antonio, TX59件の研究
- Columbus, OH57件の研究
- Washington, DC55件の研究
Bridgeportにおける他の研究
- 乳がん21件の研究
- 肺がん13件の研究
- 急性骨髄性白血病12件の研究
- 心血管疾患9件の研究
- がん（全種類）8件の研究
- 頭頸部扁平上皮癌8件の研究
- 転移性癌7件の研究
- 心不全7件の研究
- 脳動脈瘤6件の研究
- 多発性骨髄腫6件の研究
- 前立腺がん6件の研究
- 卵巣がん5件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。